SINT · XBRL financial data

Sintx Technologies financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (SINT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024†Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	594	606	1,561	2,627	2,887	1,018
Cost of revenue	475	449	265	784	811	557
Gross profit	119	157	1,296	1,843	2,076	461
Research and development	4,808	5,886	6,450	8,713	5,201	4,587
General and administrative	3,132	3,603	3,990	4,222	3,997	6,197
Total operating expenses	8,623	10,777	12,631	15,201	16,123	11,182
Operating income (loss)	(8,504)	(10,620)	(11,335)	(13,358)	(14,047)	(10,721)
Other income (expense)	282	143	382	17	39	31
Net income (loss)	(7,029)	(8,775)	(12,039)	(8,259)	(11,024)	(10,364)
Earnings per share, basic USD per share	(1.01)	(0.36)	(54.67)	(2.22)	(14.87)	(6.16)
Earnings per share, diluted USD per share	(1.08)	(0.38)	(60.81)	(3.13)	(15.19)	(6.16)
Weighted average shares, basic thousands of shares	16,407	24,692	302	3,736	741	2,774
Weighted average shares, diluted thousands of shares	17,446	25,070	317	4,357	745	2,774

† Share count changed about 1/9 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (SINT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024†Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	25,351	14,273	6,245	3,340	3,598	4,140
Inventory	487	597	737	1,221	502	825
Prepaid and other current assets	243	350	344	539	465	507
Total current assets	27,590	15,028	7,209	5,532	4,771	5,650
Property and equipment, net	471	4,025	5,691	4,826	922	476
Right-of-use asset	1,926	2,385	2,309	4,094	3,159	2,458
Goodwill	—	—	—	—	—	302
Total assets	30,447	21,840	15,773	15,365	9,413	9,506
Accounts payable	194	217	434	636	299	382
Accrued liabilities	909	1,150	1,618	1,404	986	422
Current portion of long-term debt	109	509	160	46	32	7
Total current liabilities	2,879	2,214	8,078	2,906	1,982	3,733
Long-term debt	287	—	368	—	—	—
Lease liability, non-current	1,477	1,898	1,621	3,687	3,537	2,844
Total liabilities	4,643	4,112	10,069	6,593	5,519	6,577
Accumulated deficit	(241,107)	(249,883)	(262,455)	(270,714)	(281,738)	(292,102)
Total stockholders' equity	25,804	17,728	5,704	8,772	3,894	2,929
Total liabilities and equity	30,447	21,840	15,773	15,365	9,413	9,506
Common shares outstanding (cover page) thousands of shares	24,685	24,714	3,924	22,680	2,515	4,122

† Share count changed about 1/9 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (SINT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024†Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(7,029)	(8,775)	(12,039)	(8,259)	(11,024)	(10,364)
Stock-based compensation	45	309	369	291	82	1,390
Net cash from operating activities	(9,112)	(10,132)	(10,263)	(14,115)	(8,642)	(8,571)
Purchases of property and equipment	360	3,739	1,405	530	690	185
Net cash from investing activities	1,751	(1,651)	(1,101)	(501)	(194)	913
Proceeds from issuing common stock	19,995	—	—	5,177	6,075	4,380
Share repurchases	—	—	—	—	—	133
Net cash from financing activities	30,925	705	3,336	11,711	9,094	8,200
Net change in cash	23,564	(11,078)	(8,028)	(2,905)	258	542

† Share count changed about 1/9 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Sintx Technologies	3,590	452	(2,767)*	6.7M	1.3 quarters	Q2 FY26 10-QJun 30, 2026
OSR Health	1,500	316	(2,421)*	35.1M	0.6 quarters	Q2 FY26 10-QJun 30, 2026
NutriBand	3,422	438	(585)*	12.2M	—	Q2 FY27 10-QJul 31, 2026
Tenon Medical	1,677	1,279	(2,758)*	667,047	0.6 quarters	Q2 FY26 10-QJun 30, 2026
SeaStar Medical Holding	6,959	615	(2,994)*	4.4M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
ENvue Medical	1,084	239	(2,691)*	11.1M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Bone Biologics	6,088	not reported	(532)*	3.4M	9.8 quarters	Q3 FY26 10-QSep 30, 2026
Retractable Technologies	2,641	7,201	(1,732)*	29.9M	1.5 quarters	Q2 FY26 10-QJun 30, 2026
Adm Tronics Unlimited	223	not reported	(33)	67.6M	6.8 quarters	Q1 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.